Live Cell Imaging Market Research Report – Forecast to 2023

Global Live Cell Imaging Market Research Report: Products (Equipment, Consumables, Software), Technology (Fluorescence Recovery After Photobleaching (FRAP), Others), Application (Drug Discovery, Cell Biology, Others), End-User – Global Forecast Till 2023

ID: MRFR/MED/4617-HCR | February 2021 | Region: Global | 100 pages

Market Scenario


The global live cell imaging market is expected to gain prominence over the forecast period (2018–2023). It is estimated that the global live cell imaging market is expected to grow at a CAGR ~9.0 % during the forecast period of 2018–2023.


Live cell imaging is the technique to study live cells with the help of images obtained from imaging systems such as high content screening systems and microscopes. The increasing prevalence of chronic diseases and growing government funding in cell-based research are propelling the growth of this market. For instance, funding institutes such as Health Connexions, National Institute of Health, and W.M. Keck Foundation have granted funds to institutes such as Harvard School of Medicine, Perdue University, and Weldon School of Biomedical Engineering for the development of imaging technologies to be applied in the field of health, food, and environment. Furthermore, adoption of high content screening techniques in drug discovery and cell biology boosts the growth of the global live cell imaging market.


However, the lack of availability of skilled professional and the high cost of high-content screening systems may hinder the growth of the market during the forecast period.


The global live cell imaging market is currently dominated by many players. For instance, in April 2016, BioTek Instruments launched Lionheart FX, an automated live cell imager with augmented microscopy. Moreover, the company announced the collaboration with MilliporeSigma for long-term dynamic time-lapse analyses and live cell experiments. This collaboration involved the development of an integrated solution comprising MilliporeSigma's CellASIC ONIX2 Microfluidic system and BioTek's Lionheart FX Automated Live Cell Imager. 


Research Methodology


Market Research Future research is conducted by industry experts who offer insight into industry structure, market segmentation, Treatment assessment, competitive landscape (CL), penetration, as well as on emerging trends. Besides primary interviews (~ 80%) and secondary research (~ 20%), their analysis is based on their years of professional expertise in respective industries. Our analysts also predict where the market will be headed in the next five to ten years, by analyzing historical trends and current market positions. Furthermore, the varying trends of segments & categories geographically presented are studied and are estimated based on primary & secondary research.



  • Primary Research


The extensive primary research was conducted to gain a deeper insight of the market and the industry performance. In this particular report, we have conducted primary surveys (interviews) with the key level executives (VPs, CEOs, Marketing Directors, Business Development Managers, and many more) of the major players who are active in the market. In addition to analyzing the current and historical trends, our analysts predict where the market is headed, over the next five to ten years.



  • Secondary Research


Secondary research was mainly used to collect and identify information useful for an extensive, technical, market-oriented, and commercial study of the global live cell imaging market. It was also used to obtain key information about major players, market classification and segmentation according to the industry trends, geographical markets, & developments related to the market and Treatment Perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, SEC filings, journals, white papers, corporate presentations, company websites, the international organization of chemical manufacturers, some paid databases and many others.


Key Players


Carl Zeiss AG (Germany), Leica Microsystems (Germany), Olympus Corporation (Japan), Sigma-Aldrich Corporation (U.S.), Nikon Corporation (Japan), Molecular Devices, LCC (U.S.), PerkinElmer, Inc. (U.S.), GE Healthcare (U.K.), Becton, Dickinson and Company (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Danaher Corporation (U.S.), and BioTek Instruments (U.S.) are some prominent players in this market.


Segmentation


The global live cell imaging market is segmented on the basis of the product, technology, application, and end-user.


On the basis of product, the market is classified as equipment, consumables, and software. The equipment is further segmented as microscopes, standalone systems, cell analyzer, and image-capturing devices. The microscopes are further sub-segmented as conventional microscopes, confocal microscopes, and advanced fluorescence microscopes. The consumables are sub-segmented as assay kits, reagents, media, and others.


The global live cell imaging market on the basis of technology is segmented as fluorescence resonance energy transfer, fluorescence recovery after photobleaching, high-content analysis, ratiometric imaging, fluorescence in situ hybridization, total internal reflection fluorescence microscopy, multiphoton excitation microscopy and other technologies.


On the basis of application, the market is segmented into cell biology, stem cells, developmental biology, and drug discovery.


On the basis of end-user, the market is segmented as pharmaceutical companies, biotechnology companies, hospitals, diagnostic laboratories, and others.


Geographically, the global live cell imaging market has been segmented into America, Europe, Asia Pacific, and the Middle East and Africa. The American live cell imaging market is further segmented into North America and South America. North America is further classified as the U.S. and Canada.


The Europe live cell imaging market is segmented into Western Europe and Eastern Europe. Western Europe is further classified as Germany, France, U.K., Italy, Spain, and Rest of Western Europe.


The Asia Pacific live cell imaging market is segmented into Japan, China, India, the Republic of Korea, Australia, and the Rest of Asia Pacific.


The Middle East & Africa live cell imaging market is segmented into the Middle East and Africa.


Regional Market Summary


Global Live Cell Imaging Market, by Region Market Share, 2017 (%)


 Live Cell Imaging Market


Source: MRFR Analysis


The American region holds the major share of the global live cell imaging market, owing to the existing well-established healthcare system, increasing prevalence of cancer cases, and technological advancements. According to the report published by the American Cancer Society, 2017, around 190,500 of the estimated 600,920 cancer deaths in the United States are likely to be caused owing to cigarette smoking. Moreover, factors such as high capitalization in imaging systems as well as intensive research and development to improve the imaging quality and data functionality fuel the market growth in this region.


Europe holds the second position in the global live cell imaging market. It is expected that government support towards research & development expenditure and rising prevalence chronic diseases are likely to drive the European live cell imaging market. In addition, the presence of some key players such as Carl Zeiss AG,  Leica Microsystems, and GE Healthcare in this region also facilitates the growth of this market. For instance, in November 2016, Carl Zeiss AG launched ZEISS celldiscover 7 automated microscope for live cell imaging. With this launch, the company expanded its product portfolio in live cell imaging.


The Asia Pacific live cell imaging market consists of countries, namely, China, Japan, the Republic of Korea, India, Australia, and the Rest of Asia Pacific. Japan is the largest market for live cell imaging due to an increase in the prevalence of cancer and demand for live cell imaging techniques. In China, factors responsible for the market growth are rising geriatric population with chronic diseases and availability of low-cost diagnostic and treatment options.


The Middle East & Africa holds the lowest share of the global market due to low development, lack of technical knowledge, and poor medical facilities.


Global Live Cell Imaging Market, by Product



  • Equipment

  • Microscopes

  • Conventional Microscopes

  • Confocal Microscopes

  • Advanced Fluorescence Microscopes

  • Standalone Systems

  • Cell Analyzers

  • Image-capturing Devices

  • Consumables

  • Assay Kits

  • Reagents

  • Media

  • Others

  • Software


Global Live Cell Imaging Market, by Technology



  • Fluorescence Recovery After Photobleaching (FRAP)

  • Fluorescence Resonance Energy Transfer (FRET)

  • High-content Analysis

  • Ratiometric Imaging

  • Fluorescence In Situ Hybridization (FISH)

  • Total Internal Reflection Fluorescence Microscopy (TRIF)

  • Multiphoton Excitation Microscopy (MPE)

  • Others


Global Live Cell Imaging Market, by Application



  • Cell Biology

  • Stem Cells

  • Developmental Biology

  • Drug Discovery


Global Live Cell Imaging Market, by End-user



  • Pharmaceutical Companies

  • Biotechnological Companies

  • Hospitals

  • Diagnostic Laboratories

  • Others


Global Live Cell Imaging Market, by Region



  • Americas

  • North America

  • U.S.

  • Canada

  • South America

  • Europe

  • Western Europe

  • Germany

  • France

  • Italy

  • Spain

  • U.K.

  • Rest of Western Europe

  • Eastern Europe

  • Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • Republic of Korea

  • Rest of Asia Pacific

  • The Middle East & Africa

  • Middle East

  • Africa


Company Profiles    



  • Carl Zeiss AG

  • Leica Microsystems

  • Nikon Corporation

  • Molecular Devices, LCC

  • PerkinElmer, Inc.

  • GE Healthcare

  • Becton, Dickinson, and Company

  • Olympus Corporation

  • Sigma-Aldrich Corporation

  • Thermo Fischer Scientific, Inc.

  • Danaher Corporation

  • BioTek Instruments


Intended Audience



  • Pharmaceutical Companies

  • Biotechnological Companies

  • Research and Development (R&D) Companies

  • Government Research Institutes

  • Academic Institutes and Universities



Frequently Asked Questions (FAQ) :


The live cell imaging market would record a CAGR of 9% during the forecast period of 2018 to 2023.

Lack of technical expertise and high cost of screening systems can prohibit the live cell imaging market from achieving expected growth.

Japan has the upper hand in the Asia Pacific live cell imaging market.

The North American live cell imaging market would get boosted by better research and development facilities, and a hike in investment plans for the market.

The live cell imaging market would be bolstered by industries like biotechnology companies, pharmaceutical companies, diagnostic laboratories, hospitals, and others.

Table of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Live Cell Imaging Market, by Product

6.1 Introduction

6.2 Equipment

6.2.1 Microscopes

6.2.1.1 Conventional Microscopes

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

6.2.1.2 Confocal Microscopes

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

6.2.1.3 Advanced Fluorescence Microscopes

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

6.2.2 Standalone Systems

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

6.2.3 Cell Analyzers

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

6.2.4 Image-capturing Devices

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

6.3 Consumables

6.3.1 Assay Kits

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

6.3.2 Reagents

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

6.3.3 Media

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

6.3.4 Others

6.4 Software

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

Chapter 7. Global Live Cell Imaging Market, by Technology

7.1 Introduction

7.2 Fluorescence Recovery After Photobleaching (FRAP)

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

7.3 Fluorescence Resonance Energy Transfer (FRET)

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

7.4 High-content Analysis (HCA)

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

7.5 Ratiometric Imaging

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

7.6 Fluorescence In Situ Hydridization (FISH)

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

7.7 Total Internal Reflection Fluorescence Microscopy (TRIF)

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

7.8 Multiphoton Excitation Microscopy (MPE)

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

7.9 Others

Chapter 8. Global Live Cell Imaging Market, by Application

8.1 Introduction

8.2 Cell Biology

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

8.3 Stem Cells

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

8.4 Developmental Biology

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

8.4 Drug Discovery

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

Chapter 9. Global Live Cell Imaging Market, by End-User

9.1 Introduction

9.2 Pharmaceutical Companies

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

9.3 Biotechnological Companies

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

9.4 Hospitals

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

9.5 Diagnostic Laboratories

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

9.6 Others

Chapter 10. Global Live Cell Imaging Market, by Region

10.1 Introduction

10.2 Americas

10.2.1 North America

10.2.1.1 U.S.

10.2.1.2 Canada

10.2.2 South America

10.3 Europe

10.3.1 Western Europe

10.3.1.1 Germany

10.3.1.2 France

10.3.1.3 Italy

10.3.1.4 Spain

10.3.1.5 U.K.

10.3.1.6 Rest of Western Europe

10.3.2 Eastern Europe

10.4 Asia Pacific

10.4.1 Japan

10.4.2 China

10.4.3 India

10.4.4 Australia

10.4.5 Republic of Korea

10.4.6 Rest of Asia Pacific

10.5 The Middle East & Africa

10.5.1 The Middle East

10.5.2 Africa

Chapter 11. Company Landscape

11.1 Introduction

11.2 Market Share Analysis

11.3 Key Development & Strategies

Chapter 12. Company Profiles

12.1 Carl Zeiss AG

12.1.1 Company Overview

12.1.2 Product Overview

12.1.3 Financials Overview

12.1.4 Key Developments

12.1.5 SWOT Analysis

12.2 Leica Microsystems

12.2.1 Company Overview

12.2.2 Product Overview

12.2.3 Financial Overview

12.2.4 Key Developments

12.2.5 SWOT Analysis

12.3 Nikon Corporation

12.3.1 Company Overview

12.3.2 Product Overview

12.3.3 Financial Overview

12.3.4 Key Development

12.3.5 SWOT Analysis

12.4 Molecular Devices, LCC

12.4.1 Company Overview

12.4.2 Technology/Business Segment Overview

12.4.3 Financial Overview

12.4.4 Key Development

12.4.5 SWOT Analysis

12.5 PerkinElmer, Inc.

12.5.1 Company Overview

12.5.2 Product Overview

12.5.3 Financial overview

12.5.4 Key Developments

12.5.5 SWOT Analysis

12.6 GE Healthcare

12.6.1 Company Overview

12.6.2 Product Overview

12.6.3 Financial Overview

12.6.4 Key Developments

12.6.5 SWOT Analysis

12.7 Becton, Dickinson and Company

12.7.1 Overview

12.7.2 Product Overview

12.7.3 Financial Overview

12.7.4 Key Developments

12.7.5 SWOT Analysis

12.8 Olympus Corporation

12.8.1 Overview

12.8.2 Product/ Technology Overview

12.8.3 Financials

12.8.4 Key Developments

12.8.5 SWOT Analysis

12.9 Sigma-Aldrich Corporation

12.9.1 Overview

12.9.2 Product Overview

12.9.3 Financials

12.9.4 Key Developments

12.9.5 SWOT Analysis

12.10 Thermo Fischer Scientific, Inc.

12.10.1 Overview

12.10.2 Product Overview

12.10.3 Financials

12.10.4 Key Developments

12.10.5 SWOT Analysis

12.11 Danaher Corporation

12.11.1 Overview

12.11.2 Product Overview

12.11.3 Financials

12.11.4 Key Developments

12.11.5 SWOT Analysis

12.12 BioTek Instruments

12.12.1 Overview

12.12.2 Product Overview

12.12.3 Financials

12.12.4 Key Developments

12.12.5 SWOT Analysis

Chapter 13 MRFR Conclusion

13.1 Key Findings

13.1.1 From CEO’s View Point

13.1.2 Unmet Needs of the Market

13.2 Key Companies to Watch

13.3 Prediction of the Arthroscopy Instruments Industry

Chapter 14 Appendix

LIST OF TABLES

Table 1 Global Live Cell Imaging Market Synopsis, 2018–2023

Table 2 Global Live Cell Imaging Market Estimates and Forecast, 2018–2023, (USD Million)

Table 3 Global Live Cell Imaging Market, by Region, 2018–2023, (USD Million)

Table 4 Global Live Cell Imaging Market, by Product, 2018–2023, (USD Million)

Table 5 Global Live Cell Imaging Market, by Technology, 2018–2023, (USD Million)

Table 6 Global Live Cell Imaging Market, by Application, 2018–2023, (USD Million)

Table 7 Global Live Cell Imaging Market, by End-User, 2018–2023, (USD Million)

Table 8 North America Global Live Cell Imaging Market, by Product, 2018–2023, (USD Million)

Table 9 North America Global Live Cell Imaging Market, by Technology, 2018–2023, (USD Million)

Table 10 North America Global Live Cell Imaging Market, by Application, 2018–2023, (USD Million)

Table 11 North America Global Live Cell Imaging Market, by End-User, 2018–2023, (USD Million)

Table 12 U.S. Global Live Cell Imaging Market, by Product, 2018–2023, (USD Million)

Table 13 U.S. Global Live Cell Imaging Market, by Technology, 2018–2023, (USD Million)

Table 14 U.S. Global Live Cell Imaging Market, by Application, 2018–2023, (USD Million)

Table 15 U.S. Global Live Cell Imaging Market, by End-User, 2018–2023, (USD Million)

Table 16 Canada Global Live Cell Imaging Market, by Product, 2018–2023, (USD Million)

Table 17 Canada Global Live Cell Imaging Market, by Technology, 2018–2023, (USD Million)

Table 18 Canada Global Live Cell Imaging Market, by Application, 2018–2023, (USD Million)

Table 19 Canada Global Live Cell Imaging Market, by End-User, 2018–2023, (USD Million)

Table 20 South America Global Live Cell Imaging Market, by Product, 2018–2023, (USD Million)

Table 21 South America Global Live Cell Imaging Market, by Technology, 2018–2023, (USD Million)

Table 22 South America Global Live Cell Imaging Market, by Application, 2018–2023, (USD Million)

Table 22 South America Global Live Cell Imaging Market, by End-User, 2018–2023, (USD Million)

Table 23 Europe Global Live Cell Imaging Market, by Product, 2018–2023, (USD Million)

Table 24 Europe Global Live Cell Imaging Market, by Technology, 2018–2023, (USD Million)

Table 25 Europe Global Live Cell Imaging Market, by Application, 2018–2023, (USD Million)

Table 26 Europe Global Live Cell Imaging Market, by End-User, 2018–2023, (USD Million)

Table 27 Western Europe Global Live Cell Imaging Market, by Product, 2018–2023, (USD Million)

Table 28 Western Europe Global Live Cell Imaging Market, by Technology, 2018–2023, (USD Million)

Table 29 Western Europe Global Live Cell Imaging Market, by Application, 2018–2023, (USD Million)

Table 30 Western Europe Global Live Cell Imaging Market, by End-User, 2018–2023, (USD Million)

Table 31 Eastern Europe Global Live Cell Imaging Market, by Product, 2018–2023, (USD Million)

Table 32 Eastern Europe Global Live Cell Imaging Market, by Technology, 2018–2023, (USD Million)

Table 33 Eastern Europe Global Live Cell Imaging Market, by Application, 2018–2023, (USD Million)

Table 34 Eastern Europe Global Live Cell Imaging Market, by End-User, 2018–2023, (USD Million)

Table 35 Asia Pacific Global Live Cell Imaging Market, by Product, 2018–2023, (USD Million)

Table 36 Asia Pacific Global Live Cell Imaging Market, by Technology, 2018–2023, (USD Million)

Table 37 Asia Pacific Global Live Cell Imaging Market, by Application, 2018–2023, (USD Million)

Table 38 Asia Pacific Global Live Cell Imaging Market, by End-User, 2018–2023, (USD Million)

Table 39 Middle East & Africa Global Live Cell Imaging Market, by Product, 2018–2023, (USD Million)

Table 40 Middle East & Africa Global Live Cell Imaging Market, by Technology, 2018–2023, (USD Million)

Table 41 Middle East & Africa Global Live Cell Imaging Market, by Application, 2018–2023, (USD Million)

Table 42 Middle East & Africa Global Live Cell Imaging Market, by End-User, 2018–2023, (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Live Cell Imaging Market

Figure 3 Segmentation Market Dynamics for Global Live Cell Imaging Market

Figure 4 Global Live Cell Imaging Market Share, by Product, 2017

Figure 5 Global Live Cell Imaging Market Share, by Technology, 2017

Figure 6 Global Live Cell Imaging Market Share, by Application, 2017

Figure 7 Global Live Cell Imaging Market Share, by Region, 2017

Figure 8 North America Global Live Cell Imaging Market Share, by Country, 2017

Figure 9 Europe Global Live Cell Imaging Market Share, by Country, 2017

Figure 10 Asia Pacific Global Live Cell Imaging Market Share, by Country, 2017

Figure 11 Middle East & Africa Global Live Cell Imaging Market Share, by Country, 2017

Figure 12 Global Live Cell Imaging Market: Company Share Analysis, 2017 (%)

Figure 13 Carl Zeiss AG: Key Financials

Figure 15 Carl Zeiss AG: Segmental Revenue

Figure 16 Carl Zeiss AG: Geographical Revenue

Figure 17 Leica Microsystems: Key Financials

Figure 18 Leica Microsystems: Segmental Revenue

Figure 19 Leica Microsystems: Geographical Revenue

Figure 20 Nikon Corporation: Key Financials

Figure 21 Nikon Corporation: Segmental Revenue

Figure 22 Nikon Corporation: Geographical Revenue

Figure 23 Molecular Devices, LLC: Key Financials

Figure 24 Molecular Devices, LLC: Segmental Revenue

Figure 25 Molecular Devices, LLC: Geographical Revenue

Figure 26 PerkinElmer, Inc.: Key Financials

Figure 27 PerkinElmer, Inc.: Segmental Revenue

Figure 28 PerkinElmer, Inc.: Geographical Revenue

Figure 29 GE Healthcare: Key Financials

Figure 30 GE Healthcare: Segmental Revenue

Figure 31 GE Healthcare: Geographical Revenue

Figure 32 Becton, Dickinson and Company: Key Financials

Figure 33 Becton, Dickinson and Company: Segmental Revenue

Figure 34 Becton, Dickinson and Company: Geographical Revenue

Figure 35 Olympus Corporation: Key Financials

Figure 36 Olympus Corporation: Segmental Revenue

Figure 37 Olympus Corporation: Geographical Revenue

Figure 38 Sigma-Aldrich Corporation: Key Financials

Figure 39 Sigma-Aldrich Corporation: Segmental Revenue

Figure 40 Sigma-Aldrich Corporation: Geographical Revenue

Figure 41 Thermo Fischer Scientific, Inc.: Key Financials

Figure 42 Thermo Fischer Scientific, Inc.: Segmental Revenue

Figure 43 Thermo Fischer Scientific, Inc.: Geographical Revenue

Figure 44 Danaher Corporation: Key Financials

Figure 45 Danaher Corporation: Segmental Revenue

Figure 46 Danaher Corporation: Geographical Revenue

Figure 47 BioTek Instruments: Key Financials

Figure 48 BioTek Instruments: Segmental Revenue

Figure 49 BioTek Instruments: Geographical Revenue